Literature DB >> 10944798

Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

S Yamamoto1, T Yamamoto, S Iho, T Tokunaga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944798     DOI: 10.1007/s002810050013

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  26 in total

1.  In vitro augmentation of natural killer activity of peripheral blood cells from cancer patients by a DNA fraction from Mycobacterium bovis BCG.

Authors:  H Mashiba; K Matsunaga; H Tomoda; M Furusawa; S Jimi; T Tokunaga
Journal:  Jpn J Med Sci Biol       Date:  1988 Oct-Dec

2.  In situ infiltration of natural killer-like cells induced by intradermal injection of the nucleic acid fraction from BCG.

Authors:  E Kuramoto; S Toizumi; S Shimada; T Tokunaga
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

3.  Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.

Authors:  S Iho; T Yamamoto; T Takahashi; S Yamamoto
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

4.  Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.

Authors:  D K Monteith; S P Henry; R B Howard; S Flournoy; A A Levin; C F Bennett; S T Crooke
Journal:  Anticancer Drug Des       Date:  1997-07

5.  Hexamer palindromic oligonucleotides with 5'-CG-3' motif(s) induce production of interferon.

Authors:  K Sonehara; H Saito; E Kuramoto; S Yamamoto; T Yamamoto; T Tokunaga
Journal:  J Interferon Cytokine Res       Date:  1996-10       Impact factor: 2.607

6.  Characterization and modulation of immune stimulation by modified oligonucleotides.

Authors:  R T Boggs; K McGraw; T Condon; S Flournoy; P Villiet; C F Bennett; B P Monia
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-10

7.  Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.

Authors:  S Shimada; O Yano; H Inoue; E Kuramoto; T Fukuda; H Yamamoto; T Kataoka; T Tokunaga
Journal:  J Natl Cancer Inst       Date:  1985-03       Impact factor: 13.506

8.  Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN.

Authors:  Y Kimura; K Sonehara; E Kuramoto; T Makino; S Yamamoto; T Yamamoto; T Kataoka; T Tokunaga
Journal:  J Biochem       Date:  1994-11       Impact factor: 3.387

9.  Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length.

Authors:  T Yamamoto; S Yamamoto; T Kataoka; T Tokunaga
Journal:  Antisense Res Dev       Date:  1994

10.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

Authors:  T Tokunaga; H Yamamoto; S Shimada; H Abe; T Fukuda; Y Fujisawa; Y Furutani; O Yano; T Kataoka; T Sudo
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.